麦罗塔由总部位于纽约市的辉瑞公司生产。

Mylotarg is manufactured by New York City-based Pfizer.

youdao

麦罗塔已被批准用于治疗60岁及以上伴有复发性aml且不考虑接受其他化疗的患者。

Mylotarg was approved to treat patients ages 60 years and older with recurrent AML who were not considered candidates for other chemotherapy.

youdao

在此次撤市之后，麦罗塔将来在美国的任何一种使用都将需要向FDA提交一项研究性新药申请。

Following the withdrawal, any future use of Mylotarg in the United States will require submission of an investigational new drug application to FDA.

youdao